Qualcomm slashes fiscal third quarter guidance as Apple withholds payments to contract manufacturers for Qualcomm IP

Qualcomm Inc. (QCOM), the technology and licensing company run by CEO Steve Mollenkopf, said it is slashing its guidance for fiscal third quarter revenue and earnings because Apple Inc. (AAPL) is withholding payments to its contract manufacturers who are then paying Qualcomm less than they owe. San Diego, California based Qualcomm previously said it expected [...]

(Update2) WiLAN’s decision to eschew patent acquisitions seen as one of many signs of a bottoming patent monetization market

The patent monetization market may be finally starting to show signs of a bottom given recent market changes including decisions by WiLAN Inc. (WILN) and Intellectual Ventures to flee the patent acquisition market as well as IP industry service firms such as TechInsights and CPA Global being for sale, patent market observers say. The patent [...]

By | April 27th, 2017|Patent Investing|0 Comments

Greg Wasson and Mike Otworth’s Innventure sees value in startups with patented technology

Innventure LLC, a new partnership founded by Gregory Wasson, the founder and president of Wasson Enterprise, and Mike Otworth, a former senior executive at XL Tech Group, which seeks to invest in new startups and help them commercialize their disruptive technologies, appears to pay some attention to whether that technology is patented. Venture capital investors [...]

By | April 27th, 2017|Patent Investing|0 Comments

CVI Investments, a fund managed by Heights Capital Management, takes 5.5% stake in Marathon

CVI Investments, an investment fund managed by Heights Capital Management in San Francisco, acquired 1,266,667 shares or a 5.5% stake in Marathon Patent Group (MARA), the patent licensing company run by CEO Doug Croxall, during a recent financing that raised $2.66 million. This makes CVI Los Angeles-based Marathon’s third biggest shareholder behind Jeff Feinberg, who [...]

By | April 27th, 2017|Financing, Patent Investing|0 Comments

Electronic Communications Technologies files enforcement actions against Balsam Brands, C&A Marketing and others

Electronic Communication Technologies LLC, formerly known as Eclipse IP LLC, filed enforcement actions against Balsam Brands, C&A Marketing, which does business as skymall.com and ritzcamera.com, and Lumber Liquidators in connection with a patent for a secure notification messaging system. The actions were filed by Boynton Beach, Florida-based Electronic Communication Technologies in U.S. District Court in [...]

By | April 26th, 2017|litigation, Patent Investing, Patent Trolling|0 Comments

Uniloc files enforcement actions against Atlassian and Ring Central involving patents for conference call systems

Uniloc USA Inc. and Uniloc Luxembourg, the patent monetization companies run by CEO Craig Etchegoyen, filed new enforcement actions against Atlassian Corp. PLC and RingCentral for infringement of three patents related to conference call systems. All four of the enforcement actions were filed in U.S. District Court in Marshall, Texas. The three patents in suit [...]

By | April 26th, 2017|litigation, Patent Investing, Patent Trolling|0 Comments

Finjan Mobile to offer Avira VPN product offerings under new partnership, cross license deal

Finjan Holdings Inc. (FNJN), the cybersecurity technology and licensing company run by CEO Phil Hartstein, said its Finjan Mobile Inc. unit entered into a partnership agreement with Avira Inc. East Palo Alto, California-based Finjan said Avira will provide its Virtual Private Network (VPN) Platform for distribution and sale by Finjan Mobile as part of its [...]

By | April 26th, 2017|licensing agreement, Patent Investing, Product|0 Comments

Bayer and Janssen file infringement action against Taro after it seeks FDA permission to produce a generic version of anti blood clot drug Xarelto

Bayer Intellectual Property GmbH, Bayer AG and Janssen Pharmaceuticals filed a patent infringement action against Taro Pharmaceutical Industries Ltd. and its U.S. subsidiary Taro Pharmaceuticals U.S.A. Inc. alleging infringement of a patent related to Xarelto, a drug that treats blood clots. The action filed in U.S. District Court in Wilmington, Delaware, arises out of the submission [...]

By | April 25th, 2017|drug patents, litigation, Patent Investing|0 Comments

Finjan reaches $4.9M licensing settlement with Germany’s Avira Holding GmbH

Finjan Holdings Inc. (FNJN), a cybersecurity technology and licensing company run by CEO Phil Hartstein, said its Finjan Inc. unit closed a confidential patent license agreement with Avira Holding GmbH & Co. KG for $4.9 million. East Palo Alto, California-based Finjan said Avira is a leading security software company that provides antivirus software, Internet security, [...]

By | April 25th, 2017|Europe, licensing agreement, Patent Investing|0 Comments

(Update2) Acacia says interim CEO resigns, Stewart promoted to president

Acacia Research Corp. (ACTG), the patent licensing company run by Executive Chairman Louis Graziadio III, said interim CEO Marvin Key resigned effective immediately as of April 19. Key has been interim CEO since the ouster of former CEO Matt Vella in December 2015, following an adverse ruling in an infringement suit filed by Acacia against [...]

By | April 24th, 2017|exec changes, Patent Investing|0 Comments